A novel test that looks at mucus proteins may help assess the health of the lungs in people with COPD, according to a new study.
Jupiter Endovascular, Inc., a medical technology company developing a new class of endovascular interventions using its proprietary Transforming Fixation (TFX) technology, today announced completion ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果